We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bausch Health Gets FDA Reprimand for Misleading Video and Webpage
Bausch Health Gets FDA Reprimand for Misleading Video and Webpage
The FDA’s Office of Prescription Drug Promotion (OPDP) has rapped Bausch Health for making false and misleading claims for its topical psoriasis treatment Duobrii.